Leishmania inhibits NLRP3 expression through IL-33/ST2 signaling driven SOCS1-mediated p65 degradation. Roy S, Mandal M, Banerjee M, Madbhagat P, et al. J Immunol 2026;215:vkag246.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Roy S, Mandal M, Banerjee M, Madbhagat P, et al. Leishmania inhibits NLRP3 expression through IL-33/ST2 signaling driven SOCS1-mediated p65 degradation. J Immunol 2026;215:vkag246.
PMID: 42746861